Leveraging connected diagnostics to deliver value to IVD manufacturers
The global in vitro diagnostics (IVD) market is expected to grow by nearly 50% by 2029, and this explosive growth is fueling a period of innovation–and serious opportunity.
But many IVD manufacturers are experiencing data issues that prevent them from unlocking the true value of diagnostic testing. Outdated device setup and maintenance practices, disparate and siloed data sources and manual processes are just a few of the most significant roadblocks.
In this white paper, we explore how connected diagnostics can help IVD manufacturers gain market share, encourage innovation and avoid security risks. Capabilities covered include:
- Intelligent lab workflows
- Device lifecycle and maintenance tools
- Clinician and patient solutions
- Device and consumer data insights
- Clinician real-world data engines
You’ll also find tips for choosing the right IVD platform and gain access to a case study of the end-to-end lab solution rolled out by a leading diagnostics company.
Biopharma and R&D